Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway
Kynurenine (Kyn) is a key inducer of an immunosuppressive tumor microenvironment (TME). Although indoleamine 2,3-dioxygenase (IDO)-selective inhibitors have been developed to suppress the Kyn pathway, the results were not satisfactory due to the presence of various opposing mechanisms. Here, we empl...
Saved in:
Main Authors: | Jeong Hun Kim, Won Suk Lee, Hye Jin Lee, Hannah Yang, Seung Joon Lee, so Jung Kong, Soyeon Je, Hyun-Jin Yang, Jongsun Jung, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b79d3c54e4ff44589373a0cee089c2d6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
by: Michelle Broekhuizen, et al.
Published: (2021) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
by: Mariko Seishima, et al.
Published: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
by: Corina Bello, et al.
Published: (2021) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
by: Ilona Sadok, et al.
Published: (2021)